Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.48 SEK | +10.48% | +6.10% | +29.37% |
23/05 | CombiGene AB Approves Election of Marcus Isaksson as Board Member | CI |
17/05 | CombiGene AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
58.58L | - | - | - | - | - | |
12TCr | ||||||
11TCr | ||||||
2.34TCr | - | |||||
2.18TCr | - | |||||
1.81TCr |
- Stock Market
- Equities
- COMBI Stock
- Charts CombiGene AB
- Sector Chart